Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Researchers say findings suggest it may be possible to stop cancer growth using approaches such as restraining TE activity in ...

Ultima Genomics announces that it will provide three trillion DNA sequencing reads free of charge to researchers across the United States and Canada.

The discussion covered emerging biologics, AI applications, and a strategy for supporting biomanufacturing in the current political climate.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Unlike traditional microscopes that use light or lenses, DNA microscopy creates images by calculating interactions among ...

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...